The cancer patients who have been enrolled on the Veris CCP pilot will receive a VerisBox that includes Bluetooth-enabled connected healthcare devices. Credit: Halfpoint via Shutterstock.

The first patients have been enrolled on a pilot programme launched by Pavmed’s digital health subsidiary Veris Health and the Ohio State University Comprehensive Cancer Center – Arthur G James Cancer Hospital and Richard J Solove Research Institute (OSUCCC-James). 

The companies entered a memorandum of understanding last month, detailing plans for the pilot programme for the Veris Cancer Care platform (CCP) – a digital tool for comprehensive cancer care, offering remote data collection, symptom reporting, telehealth, and electronic health record (EHR) integration. It also aims to detect complications early to reduce unplanned hospitalisations.  

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The cancer patients who have been enrolled in the Veris CCP pilot will receive a VerisBox, which includes Bluetooth-enabled connected healthcare devices. Through a smartphone app and Cloud-based Veris CCP clinician portal, the healthcare devices transmit patients’ clinical data to the cancer care team. 

Veris’ chief medical officer James Mitchell said: “We look forward to completing a successful pilot programme and continuing to execute our vision to offer enhanced personalised cancer care to the thousands of patients who receive systemic cancer therapy at the OSUCCC-James every year.” 

Remote patient monitoring (RPM) devices have gained significant attention and adoption in the healthcare industry, revolutionising the way patients are monitored and managed outside of traditional healthcare settings. According to a report on GlobalData’s Medical Intelligence Center, the RPM market will reach $760m by 2030, up from $548.90m in 2020, with a compound annual growth rate (CAGR) of 3.3% over the period. 

GlobalData is the parent company of Clinical Trials Arena.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In March 2024, Elekta and Merck & Co (MSD) teamed up to enhance care for individuals with advanced renal cell carcinoma through digital patient monitoring. The initiative utilises Elekta’s digital health interventions platform, Kaiku Health, which provides comprehensive symptom monitoring and patient support, ensuring that individuals receive tailored and timely assistance. 

In January 2024, UK-based pharmaceutical supply company Sciensus acquired the cancer patient support app, Vinehealth. The app is an oncology platform designed to allow users to report and track symptoms of disease progression in real time while allowing that same data to be shared with clinicians. The app joins Sciensus’ roster of telehealth and remote patient monitoring apps, including the company’s own InTouch app.